Suppr超能文献

透析剂量和膜通量在维持性血液透析中的作用

Effect of dialysis dose and membrane flux in maintenance hemodialysis.

作者信息

Eknoyan Garabed, Beck Gerald J, Cheung Alfred K, Daugirdas John T, Greene Tom, Kusek John W, Allon Michael, Bailey James, Delmez James A, Depner Thomas A, Dwyer Johanna T, Levey Andrew S, Levin Nathan W, Milford Edgar, Ornt Daniel B, Rocco Michael V, Schulman Gerald, Schwab Steve J, Teehan Brendan P, Toto Robert

机构信息

Baylor College of Medicine, Houston, USA.

出版信息

N Engl J Med. 2002 Dec 19;347(25):2010-9. doi: 10.1056/NEJMoa021583.

Abstract

BACKGROUND

The effects of the dose of dialysis and the level of flux of the dialyzer membrane on mortality and morbidity among patients undergoing maintenance hemodialysis are uncertain.

METHODS

We undertook a randomized clinical trial in 1846 patients undergoing thrice-weekly dialysis, using a two-by-two factorial design to assign patients randomly to a standard or high dose of dialysis and to a low-flux or high-flux dialyzer.

RESULTS

In the standard-dose group, the mean (+/-SD) urea-reduction ratio was 66.3+/-2.5 percent, the single-pool Kt/V was 1.32+/-0.09, and the equilibrated Kt/V was 1.16+/-0.08; in the high-dose group, the values were 75.2+/-2.5 percent, 1.71+/-0.11, and 1.53+/-0.09, respectively. Flux, estimated on the basis of beta2-microglobulin clearance, was 3+/-7 ml per minute in the low-flux group and 34+/-11 ml per minute in the high-flux group. The primary outcome, death from any cause, was not significantly influenced by the dose or flux assignment: the relative risk of death in the high-dose group as compared with the standard-dose group was 0.96 (95 percent confidence interval, 0.84 to 1.10; P=0.53), and the relative risk of death in the high-flux group as compared with the low-flux group was 0.92 (95 percent confidence interval, 0.81 to 1.05; P=0.23). The main secondary outcomes (first hospitalization for cardiac causes or death from any cause, first hospitalization for infection or death from any cause, first 15 percent decrease in the serum albumin level or death from any cause, and all hospitalizations not related to vascular access) also did not differ significantly between either the dose groups or the flux groups. Possible benefits of the dose or flux interventions were suggested in two of seven prespecified subgroups of patients.

CONCLUSIONS

Patients undergoing hemodialysis thrice weekly appear to have no major benefit from a higher dialysis dose than that recommended by current U.S. guidelines or from the use of a high-flux membrane.

摘要

背景

透析剂量和透析器膜通量水平对维持性血液透析患者死亡率和发病率的影响尚不确定。

方法

我们对1846例每周进行三次透析的患者进行了一项随机临床试验,采用二乘二析因设计将患者随机分配至标准剂量或高剂量透析组以及低通量或高通量透析器组。

结果

在标准剂量组中,平均(±标准差)尿素清除率为66.3±2.5%,单池Kt/V为1.32±0.09,平衡Kt/V为1.16±0.08;在高剂量组中,这些值分别为75.2±2.5%、1.71±0.11和1.53±0.09。根据β2-微球蛋白清除率估算的通量,低通量组为每分钟3±7毫升,高通量组为每分钟34±11毫升。主要结局,即任何原因导致的死亡,不受剂量或通量分配的显著影响:高剂量组与标准剂量组相比的死亡相对风险为0.96(95%置信区间为0.84至1.10;P = 0.53),高通量组与低通量组相比的死亡相对风险为0.92(95%置信区间为0.81至1.05;P = 0.23)。主要次要结局(因心脏原因首次住院或任何原因导致的死亡、因感染首次住院或任何原因导致的死亡、血清白蛋白水平首次下降15%或任何原因导致的死亡以及所有与血管通路无关的住院)在剂量组或通量组之间也没有显著差异。在七个预先指定的患者亚组中的两个亚组中显示了剂量或通量干预可能存在的益处。

结论

每周进行三次血液透析的患者似乎无法从高于美国现行指南推荐的透析剂量或使用高通量膜中获得主要益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验